KANG YANG: Open Payments
NPI 1801527841 · MENOMONEE FALLS, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$221 in 6 payments from 6 companies in 2025. Trend: 2023 $701 · 2024 $1,167 · 2025 $221
Food & beverage: $221
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $107 |
| Alkermes, Inc. | 1 | $34 |
| Axsome Therapeutics, Inc. | 1 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| ABBVIE INC. | 1 | $17 |
| Neurocrine BioSciences, Inc. | 1 | $14 |
Products named: CAPLYTA, ARISTADA, Auvelity, REXULTI, VRAYLAR, INGREZZA.
Industry payments across WI — which companies pay providers there.
